Laboratory-confirmed DR, pre-XDR, and XDR-TB cases reported in the Free State, South Africa, from 2019 to 2022, according to previous and updated WHO definitions
Introduction: The global challenge of Tuberculosis (TB) control persists, particularly in addressing drug-resistant (DR) TB across regions. Over time, the rise in rifampicin (RIF/R) resistance, multi-drug resistant TB (MDR-TB, characterised until 2022 by RIF and Isoniazid (INH) resistance), pre-exte...
Saved in:
| Main Authors: | Miss Zothile Skosana, Miss Likhona Dingiswayo, Mrs Anneke Van Der Spoel Van Dijk |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-03-01
|
| Series: | International Journal of Infectious Diseases |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S1201971224007239 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Genotypic analysis of drug-resistant tuberculosis in Ghana: Insights into pre-XDR and XDR-TB.
by: Stephen Ofori Yirenkyi, et al.
Published: (2025-01-01) -
Taking XDR TB seriously in South Africa
by: Natasha Bolognesi, et al.
Published: (2007-12-01) -
XDR TB in South Africa - What lies ahead?
by: V. Thaver, et al.
Published: (2007-12-01) -
Genotypic and Phenotypic Methods in the Detection of MDR-TB and Evolution to XDR-TB
by: Natalia Zaporojan, et al.
Published: (2025-07-01) -
Mathematical Model of MDR-TB and XDR-TB with Isolation and Lost to Follow-Up
by: F. B. Agusto, et al.
Published: (2015-01-01)